Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1891-1900 of 2787 for cancer

Edit search filters
  1. Individualized Temozolomide in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery

    Rochester, MN

  2. Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

    Rochester, MN

  3. A Study to Evaluate CTX110 in Subjects with Relapsed or Refractory B-Cell Malignancies

    Jacksonville, FL

  4. Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study Using Contrast Enhanced Digital Mammography in Addition to Diagnostic Mammography and Ultrasound for Suspicious Breast Lesions to Decrease Biopsy Rates

    Scottsdale/Phoenix, AZ

  6. 18F-DOPA-PET in Planning Surgery in Patients With Gliomas

    Rochester, MN, Scottsdale/Phoenix, AZ

  7. Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)

    Rochester, MN

  8. FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

    Rochester, MN

  9. Study of INCB053914 in Subjects With Advanced Malignancies

    Jacksonville, FL

  10. EF-41/KEYNOTE D58: Phase 3 Study Of Optune Concomitant With Temozolomide Plus Pembrolizumab In Newly Diagnosed Glioblastoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer